CAJ | 학술논문

目的探讨腹腔镜、宫腔镜联合应用在女性不孕症诊治中的疗效.方法回顾分析374例女性不孕症患者(包括原发性及继发性不孕)应用腹、宫腔镜联合诊治的临床资料.分析其病因;比较腹、宫腔镜联合检查和单独检查结果的差异;比较子宫输卵管碘油造影与输卵管插管通液的通畅率,观察输卵管手术后的再通率.结果不孕病因主要有盆腔粘连(占50.80)%,输卵管阻塞(占42.25%),盆腔子宫内膜异位症(占25.67%),子宫内膜息肉(占13.90%),多囊卵巢(占11.76%),子宫肌瘤(占6.42%).腹、宫腔镜联合检查阳性率高于二者单独检查.输卵管插管通液/疏通术较子宫输卵管造影通畅率差异有显著性(P＜0.01),腹、宫腔镜联合手术后输卵管再通率为40.92%.结论应用宫腔镜、腹腔镜联合诊治术能直观、准确、全面地了解不孕症在盆腔、宫腔方面的病因,并予以针对性治疗.
목적 탐토복강경、궁강경연합응용재녀성불잉증진치중적료효.방법 회고분석374례녀성불잉증환자(포괄원발성급계발성불잉)응용복、궁강경연합진치적림상자료.분석기병인;비교복、궁강경연합검사화단독검사결과 적차이;비교자궁수란관전유조영여수란관삽관통액적통창솔,관찰수란관수술후적재통솔.결과 불잉병인주요유분강점련(점50.80)%,수란관조새(점42.25%),분강자궁내막이위증(점25.67%),자궁내막식육(점13.90%),다낭란소(점11.76%),자궁기류(점6.42%).복、궁강경연합검사양성솔고우이자단독검사.수란관삽관통액/소통술교자궁수란관조영통창솔차이유현저성(P＜0.01),복、궁강경연합수술후수란관재통솔위40.92%.결론 응용궁강경、복강경연합진치술능직관、준학、전면지료해불잉증재분강、궁강방면적병인,병여이침대성치료.
Objective To study the effects of hysteroscope combined with abdominoscope on the diagnosis and therapy of female infertility.Methods Clinical data of being diagnosed and therapied with hysteroscope and abdominoscope in 374 infertility cases were retrospectively analyzed.Explained the etiological factors and compared the positive rates among hysteroscope combined with abdominoscope,hysteroscope alone and abdominoscope alone.The patency rates were compared between hysterosalpingography and hydrotubation,and the recanalization rates of uterine tubes after operations were observed.Results The main causes of female infertility were pelvic affixion(50.80%),salpingemphraxis(42.25%),pelvic endometriosis(25.67%),endometrial polypus (13.90%),polycystic ovary(11.76%)and hysteromyoma(6.42%).The positive rate of hysteroscope combined with abdominoscope was obviously higher than the others.There was a significant deviation of oviductal patency rates between hysterosalpingography and hydrotubation.The recanalization rate of uterine tubes after the operation was 40.92%.Conclusion Hysteroscope combined with abdominoscope could comprehend the etiopathogenisis and heal the diseases of infertility in cavitas pelvis and uterine cavity with advantage of directly,exactly and overall.